Cited by 213Cancer, Hypoxia, and MetabolismErythropoietin and Anemia TreatmentKruppel-like factors research

Roles of the human hypoxia-inducible factor (HIF)-3α variants in the hypoxia response

Open access
Heikkilä, Minna, Pasanen, Annika, Kivirikko, Kari I., Myllyharju, Johanna·2011·Cellular and Molecular Life Sciences

Abstract

The hypoxia-inducible transcription factor (HIF) controls (in an oxygen-dependent manner) the expression of a large number of genes whose products are involved in the response of cells to hypoxia. HIF is an αβ dimer that binds to hypoxia response elements (HREs) in its target genes. Human HIF-α has three isoforms, HIF-1α, HIF-2α and HIF-3α, of which the roles of HIF-3α are largely unknown, although it is usually regarded as a negative regulator of HIF-1α and HIF-2α. The human HIF-3α locus is subject to extensive alternative splicing, leading to at least seven variants. We analyzed here the effects of the long variants and the short variant HIF-3α4 on the hypoxia response. All these variants were found to interact with HIF-β, HIF-1α and HIF-2α. The long HIF-3α variants were localized in the nucleus in hypoxia, while HIF-3α4 was cytoplasmic. Interaction of the HIF-3α variants with HIF-1α inhibited the nuclear translocation of both. None of the long HIF-3α variants was capable of efficient induction of an HRE reporter in overexpression experiments, but instead inhibited the transcriptional activation of the reporter by HIF-1 and HIF-2. Unexpectedly, siRNA knock-down of the endogenous HIF-3α variants led to downregulation of certain HIF target genes, while overexpression of individual long HIF-3α variants upregulated certain HIF target genes in a variant and target gene-specific manner under conditions in which HIF-β was not a limiting factor. These data indicate that the HIF-3α variants may have more versatile and specific roles in the regulation of the hypoxia response than previously anticipated.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00018-011-0679-5

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HIF-3 shares transcriptional targets with HIF-1 and HIF-2, including EPO, GLUT1, ANGPTL4, REDD1 (DDIT4), LC3C, and SQRDL.

    “Indeed, HIF-3 shares transcriptional targets with HIF-1 and HIF-2, including EPO, GLUT1, ANGPTL4, REDD1 (DDIT4), LC3C, and SQRDL [59,101,108,112]”

    From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [108]

    The Results (Figs. 6–7; page not provided) show that HIF-3α variants affect expression of EPO, ANGPTL4 and GLUT1, which the paper identifies as HIF target genes. The effects vary by variant and experimental condition. Our copy does not establish REDD1 (DDIT4), LC3C or SQRDL as HIF-3α targets. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Under conditions of limiting HIF-β availability, overexpression of HIF-3α can promote cytoplasmic aggregation with HIF-1α or HIF-2α, preventing nuclear localization.

    “Under conditions of limiting HIF-β availability, overexpression of HIF-3α can promote cytoplasmic aggregation with HIF-1α or HIF-2α, preventing nuclear localization [108]”

    From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [108]

    The Discussion (page unavailable) says that when HIF-β is limiting, HIF-3α variants can associate with HIF-1α and HIF-2α. The cellular-localization results (page unavailable) show that coexpressed HIF-3α variants and HIF-1α remain cytoplasmic and fail to accumulate in the nucleus. The paper describes complexes, not cytoplasmic aggregation, and does not show that HIF-3α prevents HIF-2α nuclear localization. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 39 · Cited by 213

Authors
Heikkilä, M., Pasanen, A., Kivirikko, K. I., & Myllyharju, J.
Affiliations
University of Oulu (FI)
Corresponding author
Myllyharju, Johanna
Venue
Cellular and Molecular Life Sciences
Published
2011-04-10
Volume
68
Issue
23
Pages
3885-3901
ISSN
  • 1420-682X (ISSN-L)
  • 1420-9071
OpenAlex
W1996463890
Cited by
213
References
39
Citations by year
2026: 10 · 2025: 9 · 2024: 12 · 2023: 17 · 2022: 16 · 2021: 8 · 2020: 17 · 2019: 16 · 2018: 14 · 2017: 14 · 2016: 19 · 2015: 23 · 2014: 13 · 2013: 14 · 2012: 8
FWCI
4.14
Type
journal article
Language
en
Open access
Locations
  • Cellular and Molecular Life Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
FibroGen
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
Keywords
HIF-3α, hypoxia-inducible factor, hypoxia response, alternative splicing, HIF-1α, HIF-2α, nuclear translocation, transcriptional activation, HIF target genes, siRNA knockdown
MeSH terms
Humans, Repressor Proteins, Tumor Cells, Cultured, Genetic Variation, Cell Hypoxia, RNA, Small Interfering, Apoptosis Regulatory Proteins, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review